Clinical Trial Update: Economic Analysis of Alliance A041202 CLL Study

View source ↗

Summary

This document provides an economic analysis of the Alliance A041202 study in chronic lymphocytic leukemia, outlining cost-effectiveness considerations.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia

Snippet

Sponsor: Canadian Cancer Trials Group | Conditions: Chronic Lymphocytic Leukemia | Status: ACTIVE_NOT_RECRUITING